Home/Filings/4/0000899243-22-019372
4//SEC Filing

SkyKnight Capital Fund II, L.P. 4

Accession 0000899243-22-019372

CIK 0001725255other

Filed

May 23, 8:00 PM ET

Accepted

May 24, 4:43 PM ET

Size

14.8 KB

Accession

0000899243-22-019372

Insider Transaction Report

Form 4
Period: 2022-05-20
Transactions
  • Purchase

    Common Stock

    2022-05-24$17.27/sh+100,000$1,727,2302,893,843 total
  • Purchase

    Common Stock

    2022-05-23$17.44/sh+9,300$162,1582,793,843 total
  • Purchase

    Common Stock

    2022-05-20$17.33/sh+100,000$1,732,9402,784,543 total
Holdings
  • Common Stock

    (indirect: By LLC)
    5,662,814
Transactions
  • Purchase

    Common Stock

    2022-05-23$17.44/sh+9,300$162,1582,793,843 total
  • Purchase

    Common Stock

    2022-05-20$17.33/sh+100,000$1,732,9402,784,543 total
  • Purchase

    Common Stock

    2022-05-24$17.27/sh+100,000$1,727,2302,893,843 total
Holdings
  • Common Stock

    (indirect: By LLC)
    5,662,814
Transactions
  • Purchase

    Common Stock

    2022-05-23$17.44/sh+9,300$162,1582,793,843 total
  • Purchase

    Common Stock

    2022-05-20$17.33/sh+100,000$1,732,9402,784,543 total
  • Purchase

    Common Stock

    2022-05-24$17.27/sh+100,000$1,727,2302,893,843 total
Holdings
  • Common Stock

    (indirect: By LLC)
    5,662,814
Footnotes (5)
  • [F1]The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $16.99 to $17.50. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request.
  • [F2]Shares held by SkyKnight Capital Fund II, L.P. "("SkyKnight Fund II"). SkyKnight Capital II GP, LLC ("SkyKnight II GP") is the general partner of SkyKnight Fund II. Matthew Ebbel is the managing member of SkyKnight II GP. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any.
  • [F3]The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $17.21 to $17.50. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request.
  • [F4]The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $17.00 to $17.50. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request.
  • [F5]Shares held by SkyKnight Aero Holdings, LLC ("SkyKnight Aero Holdings"). SkyKnight Capital, L.P. ("SkyKnight Capital") is the manager of SkyKnight Aero Holdings. SkyKnight Capital Management, LLC ("SkyKnight Capital Management") is the general partner of SkyKnight Capital. Matthew Ebbel is the managing member of SkyKnight Capital Management. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any.

Issuer

AdaptHealth Corp.

CIK 0001725255

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001748212

Filing Metadata

Form type
4
Filed
May 23, 8:00 PM ET
Accepted
May 24, 4:43 PM ET
Size
14.8 KB